» Articles » PMID: 35099674

Clinical Phenotypes, Hemodynamic Characteristics and Prognosis of Chinese Patients with Systemic Sclerosis-associated Precapillary Pulmonary Hypertension: a Retrospective Study

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2022 Jan 31
PMID 35099674
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Systemic sclerosis (SSc) is associated with interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH). This study aimed to explore the prevalence, clinical features, hemodynamic characteristics and prognosis of different severity of ILD in a cohort of patients with SSc-associated precapillary pulmonary hypertension (SSc-PH) and investigate the differences between SSc-PAH and idiopathic pulmonary arterial hypertension (IPAH) patients.

Method: SSc-PH patients and IPAH patients, admitted to Shanghai Pulmonary Hospital (August 1, 2008-January 31, 2020) and diagnosed by right-sided heart catheterization (RHC) or echocardiography, were retrospectively included. SSc-PH patients had a baseline chest high-resolution computed tomography (HRCT), and PH classification was based on the extent of ILD. Clinical, pulmonary function, hemodynamic characteristics and survival data were extracted.

Results: The study included 45 SSc-PH patients (60% had coexisting ILD and 77.8% were SSc-Group 1 PH/SSc-PAH [without ILD or with mild ILD], 22.2% were SSc-Group 3 PH/SSc-PH with severe ILD) and 52 IPAH patients. SSc-PH with ILD had lower arterial oxygen partial pressure (PaO) than those without ILD. Hemodynamic characteristics and survival rates were comparable between SSc-PAH with mild ILD and those without ILD. SSc-Group 3 PH had lower pulmonary vascular resistance (PVR) and more severe restrictive ventilatory dysfunction than SSc-Group 1 PH, but the survival rate was equally poor. SSc-PAH had a poorer prognosis than IPAH patients despite the better hemodynamic characteristics.

Conclusions: ILD was common in SSc-PH patients. Careful phenotyping of PH in SSc-PH patients is very important as it is imperative to recognize its impact on clinical course, treatment and survival.

Key Points: • ILD was common in Chinese SSc-PH patients. • SSc-PH patients with ILD had lower PaO than those without ILD. • Hemodynamic characteristics and survival rates were similar in SSc-PAH patients with mild ILD and those without ILD. • Patients in SSc-Group 3 PH had lower pulmonary vascular resistance (PVR) and more severe restrictive ventilatory dysfunction than those in SSc-Group 1 PH, but the survival rate was equally poor. SSc-PAH patients had a poorer prognosis than IPAH patients despite their better hemodynamic characteristics.

Citing Articles

Umbilical cord mesenchymal stem cells transplantation in patients with systemic sclerosis: a 5-year follow-up study.

Alip M, Wang D, Zhao S, Li S, Zhang D, Duan X Clin Rheumatol. 2024; 43(3):1073-1082.

PMID: 38206544 DOI: 10.1007/s10067-024-06865-z.


Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.

Petelytska L, Bonomi F, Cannistra C, Fiorentini E, Peretti S, Torracchi S RMD Open. 2023; 9(4).

PMID: 37940340 PMC: 10632935. DOI: 10.1136/rmdopen-2023-003426.


Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?.

Khan S, Mathai S Curr Opin Pulm Med. 2023; 29(5):380-390.

PMID: 37461869 PMC: 11334969. DOI: 10.1097/MCP.0000000000001001.

References
1.
Pattanaik D, Brown M, Postlethwaite B, Postlethwaite A . Pathogenesis of Systemic Sclerosis. Front Immunol. 2015; 6:272. PMC: 4459100. DOI: 10.3389/fimmu.2015.00272. View

2.
Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A . Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017; 76(11):1897-1905. DOI: 10.1136/annrheumdis-2017-211448. View

3.
Poudel D, Jayakumar D, Danve A, Sehra S, Derk C . Determinants of mortality in systemic sclerosis: a focused review. Rheumatol Int. 2017; 38(10):1847-1858. DOI: 10.1007/s00296-017-3826-y. View

4.
Steen V, Medsger T . Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007; 66(7):940-4. PMC: 1955114. DOI: 10.1136/ard.2006.066068. View

5.
Galie N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A . 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):.... Eur Respir J. 2015; 46(4):903-75. DOI: 10.1183/13993003.01032-2015. View